Contact this trialFirst, we need to learn more about you.
Histone Deacetylase Inhibitor
Romidepsin for Cancer and Chronic Lymphocytic Leukemia with Liver Dysfunction
Recruiting1 awardPhase 1
Atlanta, Georgia
This trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.